EMEA-001739-PIP02-16-M01

Key facts

Active substance
  • ketamine (hydrochloride)
  • sufentanil citrate
Therapeutic area
Pain
Decision number
P/0177/2022
PIP number
EMEA-001739-PIP02-16-M01
Pharmaceutical form(s)
Nasal spray, solution
Condition(s) / indication(s)
Treatment of acute pain
Route(s) of administration
Intranasal use
Contact for public enquiries
Cessatech A/S

E-mail: info@cessatech.com
Tel: +45 93872309  

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating